AngioDynamics, Inc. (ANGO) stock analysis

In our weekly check, AngioDynamics, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 9 pass, warnings: 5, red flags: 8.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NASDAQ as ANGO.

What our checks show for ANGO

Red flags

Warning signs

Strengths

Next earnings report: 2027-01-06

Similar companies

SMTI · STAA · AZTA · KMTS · XRAY · LMAT

Questions

What grade does AngioDynamics, Inc. (ANGO) have?

In our weekly check, AngioDynamics, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 9 pass, warnings: 5, red flags: 8. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ANGO stock?

This week's biggest flags for AngioDynamics, Inc.: Weak interest cover, Weak revenue growth, Weak EPS growth. In total 13 of 22 checks show a warning or a red flag.

What does AngioDynamics, Inc. do?

AngioDynamics, Inc. is a Healthcare company (Medical Instruments & Supplies) based in the United States, listed on NASDAQ as ANGO.

When does AngioDynamics, Inc. report earnings next?

The next earnings report is expected on 2027-01-06. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis